Piper Sandler Adjusts Price Target on Connect Biopharma Holdings to $1.75 From $1.50, Maintains Neutral Rating
Piper Sandler Adjusts Price Target on Connect Biopharma Holdings to $1.75 From $1.50, Maintains Neutral Rating
派珀·桑德勒将Connect Biopharma Holdings的目标股价从1.50美元调整为1.75美元,维持中性评级
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册